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~6~ Non-LlnaaHty of the LA Prsallurs-Voluma 
Ralatlonlhlp: An Intraoperatlva Echocardlographlc 
Study 
M,J, Gareth, N, Smedira. N, Groenboro, J, Won~}, L, Rodrigao~, 
J,D Thom~m, Tt~o Cleveland Clinic Foundation, Cleveland, OH, USA 
~ack~round" In,vitro nnd animal studla~ augge~t l~at LA prae,ura.volumo 
relationship I~ non.linear, incroaelng at hlgheP load, 
Mothod~: We etodlod 9 patlenfe (pie) undo+toeing hoarl sgrg~n/bolero 
(BI;PB) and during partial omdiopulmon~ry byp~es (POPe) to alter loading 
(~ondltlon,, Hlgl~ fidelity LA proe~aro (LAp) and polmonary vonoua Doppler 
volooltloa word digitally t+torod and analyzed off,linD, Pro.sy~tollo LA volamoe 
(LAV) word mo~utod ochogardlogrophyeally a,lng opicl~rdlal tranduooro, In. 
~tant~nooue ¢lmngo~ in LA volume (dV/dl) during LV syotola wore eetimafod 
ae a ratl~ el Watollc to total velocity time Intot]ral of tl~o pulmonary rondos 
(PV) (Iow~ mulltpliod by LV etroko volume, In 3 pie wltl~ mitral regorgita. 
lion, rogurgltant volume wee e~tlmatod ualng the proximal Ilow convergence 
method and oddod, LA etiltno~e ((dpldt)l(dVIdl)) wee calculated at OCPB and 
PCPB, 
Ro,~tltll, (Moan ~ ~ID): 
~l~Qe OCPI~ PCPD p 
~lnlk~ ~olun.+ (,~:) 4; ~ 14 3t ~ 11 000'+1 
Ple.~y~toh~ LAV 6~ + 4(i 49 , +'19 0 06 
Pr~,sy~lol~LAp t7 i 6 1~ ~ 5 004 
LA C+tiltnr~t~ 0 311 ~ 001~ e 10 t 13 14 003 
Concl(~iO~lS: Outing vontrCular systole LA sttllnose incroaeoa at higher 
LA pr~seuro, indicating a non.linear volume proseuro relationship These 
hndlnge provide an explanation tot the development el PV flow systolic 
blunting and reversal in pte with LV dysfunction and eovoro MR. 
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~ Traneeeophageal 3-Dimensional Echocardlographic 
Study of Coronary Arteries: Methodology, Feasibility 
and Location of Coronary Artery Stenosla 
J, Yao, M,A, Teams, P J, do Foijter, F,J, Ten Cote, LA, van HonNerdon, 
J,R,T,C, Rootandt Thor~xcenfer, Erasmas University Rotterdam, The 
Netherlands 
Three-dimensional transesophageal ochecardiography (3DTEE) results in 
h+gh resolution images of the heart. How well it can be used for examining the 
coronar~ arteries (CA) and for detecting CA stenosls is of clinical significance 
in predicting ischamic events. 
Am} To oxamme the feasibility and methodology ot 3DTEE in visualizing 
CA and detecting stenotic lesions. 
Methods: 3DTEE was performed using rotational scanning at mid.esoph- 
ageal window with a 30 acquisition system integrated in a commercially 
available ultrasound unit with ECG and respiratory gating. Of the 46 pls (age 
18-85 yrs) studied, 25 were consecutive undenNent routine TEE exam and 
21 underwent cardiac surgery. Amen9 them, 28 had CA angiography (CAA) 
and stonoses of 1 or more segments were found in 16 pts. 3DTEE was 
analyzed using secondarily derived 2D views, CA lumen extraction and 30 
reconstruction to obtain the origin and path of CA and site of ..~tenosis. 
Results: In all patients, various segments of CA were examined along 
with other cardiac structures, The obse~ed f;oquency/length of the left main, 
circumflex, anterior descending and right CA were 100%/4-22 (12 ± 4) 
mm, 100%/6-36 (15 ~+: 6) am, 98%/13-60 (30 ± 12) mm and 72%/6-36 
(18 * 9) am, respectively, In those 28 pts wilh CAA, 53 of 1 t8 segments 
showed various degrees of stenosis by 3DTEE. In comparison with CAA, 
the sensitivity, specificity, positive and negative predictive value of 3DTEE 
Ior detecting CA stenosis were 85%, 80%, 79% and 86%, respectively. In 
addition, t!~e spatial pathways and variations of CA was also obtained. 
Conclusion: 3DTEE yields good definition and useful information about 
the proximal segments of CA and may be applied clinically to detect stenotic 
lesions. 
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~Tha BonMIclM Elfoct of a High-Fat, High.Protein, 
Low.Carbohydrate Diet on Body Weight and flOL 
CholoMorol 
F Lopot.Jimono++, R, Hollbron, M, Airman, H+ Kern, GA Lamas, 
A,~, Agatetort Mount S/nat Me, dicer Center and fh# Unwomity el Mi~m~ 
SchOol of Medic~no, Miami Oe~lC, tt, FL, U~ 
8ackoro¢mrl; Low.fat, high.carbOhydrate (CHO) dials d~roae~ Ig0|h L_ [}L 
HIDL Ch01eStOrol aed t:~ra esot;i~ted with poor patient compli~llCO, 
Mgfhod,9: To teat the fifle~tiv~n~sJs ol ~ tow.GHO, re+!~liv~ly high.l~t ~nd 
high.protein (PR) di~l on weight iose and !ipids, we pTos~live!y asse.%~ 
78 ovorweigl~t p+ltioete (10~.B I ~16 Ibm), 63% males, moan agj0 01.~ ~ t2+ 
years with a mean f011ow+up o! 13;~ day@. The diet conei~tod of four stages l) 
10% CHO, +8% PR, (~% fat for two waoke; !!) ~7% CHO, 33% PR, 40% fat 
tar two weeks; lU) 36% CHO, 30% PR, 34% fat for two weeks; IV! 45% CHO, 
30% PR, ~5% fat for tl~e remainder of the diet period. Only carbohydrate 
calories were restricted 
Rt~IIs: The Ovolall weight Ios~ was 72 + 11.3 Ibs, p =. 00001, and 
11,3 :l Z,7 Ib~, D ~ 0.0001 among the 77% el patients who !Oat at least 1 
Ib. $orom HDL choleeterol increased 7.2 :~ 41 mg/dl (15%), p = 0.027 in 
tile overall group, and 9.8 L 47 m~dl (20%), p =+ 0.001 in patients who 
did lose weight. Triglycerido levels decreased 36.6 mg+ul tt9%) p = 0.004. 
and 36,0 :t 75 mg/dl (20%) p = 0.004 in the total sample and in those 
wire lost weight, respectively. Total cholesterol ~nd LOL cholesterol did net 
cl~ango significantly. The majority o1 patients (92%) reported that they would 
recommend the diet to others. 
Conclusions: A Iow-carbehydralo, relatively high-let and high+premm diet 
was associated with significant weight loss and an improved lipid profite. 
Prospective studios companng this diet with more conventional high carbo- 
hydrate, low+fat diets are needed. 
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~ Attainment of LDL-Cholesterol Goals in a National 
Sample: Results From the Lipid Treatment 
Assessment Project (L-TAP) 
TA  Pearson, IM. Laumra. For L-TAP: Parka-Davis. Dwision et 
Wamer.LamDert Company Morris Plains, N J, USA 
The National Cholesterol Education Program Adult Treatment Panel II has 
recommended LDL-cholesterol (LDL-C) goals for the treatment of hypem- 
holesterelemta, but the extent to which these goals are reached in typical 
primary care practices is poedy defined. To study this. we surveyed 901 pri- 
mary care physicians in all regions of the U.S. who are frequent prescribers of 
lipid-lowering drugs. Each physician then submitted clinical data and a last- 
ing blood sample from sequentially selected patients currently being treated 
for hyporcholesterelemia. A total of 5,601 patients were enrolled. Treatment 
success was defined by attainment of LDL-C goal for low risk (4 t risk factor), 
high risk (22 dsk factors) or coronary heart disease (CHD) patients. Overall, 
frequency of treatment success varied significantly by risk grOup (P < 0.001 ) 
and non-drug versus drug therapy (P ~ 0.001): 
Percent Success 
Risk Group LDL-C Goal  Non.drug Rx Drug Rx Overall 
Low - 160 mg/dl 59 70 69 
High + 130 mg/dl 22 40 37 
CHD 100 mgidl 7 18 18 
Factors associated with these low rates el success were: lack of drug 
therapy in high risk groups, use of low doses of drugs, lack of use of drug 
combinations, and drug combinations not including a statin. Despite clinical 
trials der onstrating efficacy of lowering LDL-C in high risk groups, a majority 
of these patients are not currently at their LDL-C goal. Physicians need to 
improve their skills in prescribing treatments which optimize LDL-C levels. 
